Cold Exposure and Oral Delivery of GLP-1R Agonists by an Engineered Probiotic Yeast Strain Have Antiobesity Effects in Mice.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Cold Exposure and Oral Delivery of GLP-1R Agonists by an Engineered Probiotic Yeast Strain Have Antiobesity Effects in Mice.
- Published In:
- ACS synthetic biology, 12(11), 3433-3442 (2023)
- Authors:
- Hedin, Karl Alex, Zhang, Hongbin, Kruse, Vibeke, Rees, Vanessa Emily, Bäckhed, Fredrik, Greiner, Thomas U, Vazquez-Uribe, Ruben, Sommer, Morten Otto Alexander
- Database ID:
- RPEP-06948
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06948APA
Hedin, Karl Alex; Zhang, Hongbin; Kruse, Vibeke; Rees, Vanessa Emily; Bäckhed, Fredrik; Greiner, Thomas U; Vazquez-Uribe, Ruben; Sommer, Morten Otto Alexander. (2023). Cold Exposure and Oral Delivery of GLP-1R Agonists by an Engineered Probiotic Yeast Strain Have Antiobesity Effects in Mice.. ACS synthetic biology, 12(11), 3433-3442. https://doi.org/10.1021/acssynbio.3c00455
MLA
Hedin, Karl Alex, et al. "Cold Exposure and Oral Delivery of GLP-1R Agonists by an Engineered Probiotic Yeast Strain Have Antiobesity Effects in Mice.." ACS synthetic biology, 2023. https://doi.org/10.1021/acssynbio.3c00455
RethinkPeptides
RethinkPeptides Research Database. "Cold Exposure and Oral Delivery of GLP-1R Agonists by an Eng..." RPEP-06948. Retrieved from https://rethinkpeptides.com/research/hedin-2023-cold-exposure-and-oral
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.